Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

http://www.sciencebasedmedicine.org/?p=5166

This is a great article from the sciencebasedmedicine guys about the state of dichloroacetate as a cancer treatment. A bit long-winded, but totally realistic about the current prospects. The links at the bottom are all great too.



Great article. Here's a summary (or at least how I understood it) for those that don't read it (which I recommend you do):

* Mitochondrias (an organele in our cells that is considered the battery of a cell) in cancer patients typically don't function as they normally should.

* In 2007, University of Alberta researchers led by Evangelos Michelakis, announced a non-human trial that showed promising signs of stopping and regressing cancer using a substance known as DMC.

* DMC is thought to work by fixing bad mitochondrias in cancer patients (obviously over simplified).

* DMC is non-patentable and is easily made, so the news became a big anti-big-pharma story and spread like wild fire because the researchers were having trouble getting funds for doing clinical trials, since there was no money that could be made from this drug if it proved to work.

* The hopes for many cancer patients skyrocketed creating demand for DMC.

* A few ethically challenged entrepreneurs setup websites to sell DMC under the guise of DMC for Pets to get around FDA.

* There are potential side-effects when DMC is mixed with other drugs so a lot of people put their their lives in danger by doing self treatment, but no results were ever posted to the forums. The suspected reason is that the forum admins removed all negative reports.

* The websites were shut down by FDA after some time.

* A couple days ago, Michelakis's team at UofA announced the results of a clinical trial in which they administered DMC to 5 patients. This published in a journal but you can see their announcement at http://www.dca.med.ualberta.ca/Home/Updates/2010-05-12_Updat...

* Of the 5, patient #1, #2 & #5 showed promising results. Patient #3 died (not attributed to DMC) and patient #4 needed a 2nd surgery 3 months after starting, which it didn't specifically say but I assumed to mean that it wasn't considered successful.

* Key things to note:

  - the trials where a combination of phase 0 
    and phase 1 trials. 

  -- Phase 0 = seek to determine if the drug 
     is doing biochemically what it is expected 
     to do based on preclinical studies, usually 
     by taking a biopsy and doing chemical tests.
  
  -- Phase 1 "are designed to determine two things: 
     dose and dose-limiting side effects" ... 
     not efficacy of the drug.

  - all 5 were treated differently and in 
    combination with other treatments. 
    This makes the tests not reliable 
    enough to make conclusions from. 

  - Treatments often show very very promising 
    signs when dealing with non-humans but fail 
    when the rubber meets the road in real 
    clinical trials.
  
  - DMC shows promise but it's dangerous for 
    people to self-treat and inefficient to 
    shortcut the scientific process of testing 
    and evaluating treatments.


Oops, I said DMC instead of DCA.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: